Menu
Currency
GWAS Study

An Intergenic Variant rs9268877 Between HLA-DRA and HLA-DRB Contributes to the Clinical Course and Long-term Outcome of Ulcerative Colitis.

Lee HS, Yang SK, Hong M et al.

29905830 PubMed ID
GWAS Study Type
854 Participants
34 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

LH
Lee HS
YS
Yang SK
HM
Hong M
JS
Jung S
KB
Kim BM
MJ
Moon JW
PS
Park SH
YB
Ye BD
OS
Oh SH
KK
Kim KM
YY
Yoon YS
YC
Yu CS
BJ
Baek J
LC
Lee CH
HB
Han B
LJ
Liu J
HT
Haritunians T
MD
McGovern DPB
SK
Song K
Chapter II

Abstract

Summary of the research findings

Background and aims: The genetic contribution to the prognosis of ulcerative colitis [UC] is poorly understood, and most currently known susceptibility loci are not associated with prognosis. To identify genetic variants influencing the prognosis of UC, we performed an Immunochip-based study using an extreme phenotype approach.

243 Korean ancestry poor prognosis cases, 364 Korean ancestry good prognosis controls

Chapter III

Study Statistics

Key metrics and study information

854
Total Participants
GWAS
Study Type
Yes
Replicated
145 Korean ancestry poor prognosis cases, 129 Korean ancestry good prognosis controls
Replication Participants
East Asian
Ancestry
Republic of Korea
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.